Clinically, the expression of heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and PKM2 has been reported to be upregulated in patients with sorafenib-resistant HCC and is inversely correlated with the expression level of miR-374b [175]. The gene discussed is PKM; the disease is hepatocellular carcinoma.